Progyny
PGNY
27.55
+1.64
+6.33%
Progyny
US · PGNY
#2809 by market cap
Listed 2019
27.55
+1.64
+6.33%
Live - 5344 symbols - heartbeat 540s ago
· 2026-10-08 08:01
Pre-market
28.50
+3.45%
After-hours
28.09
+1.96%
- Market cap
- 2.11B
- P/E (TTM)i
- 29.95
- P/Bi
- 4.66
- EPSi
- 0.65
- Div yieldi
- 0.00%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on PGNY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 110.57% -0.29pp
- Institutions
- 381 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund81.02%
Hedge Fund11.14%
VC/PE Fund6.61%
Insurance Company3.91%
Public Company2.78%
Private Company2.77%
Government Pension Fund1.87%
Individual/Insider1.81%
Sovereign Wealth Fund0.20%
Top holders as of 2026-06-30
BlackRock
15.12% · 11.60M sh
FMR
9.13% · 7.00M sh
Kleiner Perkins Caufield & Byers LLC
6.61% · 5.07M sh
Vanguard Portfolio Management, LLC
6.54% · 5.02M sh
Vanguard Capital Management, LLC
4.86% · 3.73M sh
State Street Global Advisors
3.94% · 3.02M sh
Columbia Management Investment Advisers, LLC
3.60% · 2.76M sh
Fort Washington Investment Advisors, Inc.
3.32% · 2.55M sh
Geode Capital Management, LLC
2.57% · 1.97M sh
Citadel Advisors LLC
2.33% · 1.79M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 17 buys · 33 sells
| Name | Role | Stake |
|---|---|---|
| Peter Anevski | Chief Executive Officer | 0.76% |
| Norman Payson | Independent Director | 0.59% |
| David Schlanger | Executive Chairperson | 0.31% |
| Allison Swartz | General Counsel | 0.03% |
| Jeffrey Park | Independent Director | 0.03% |
| Kevin Gordon | Independent Director | 0.02% |
| Cheryl Scott | Independent Director | 0.02% |
| Roger Holstein | Independent Director | 0.02% |
| Lloyd Dean | Independent Director | 0.02% |
| Geoffrey Clapp | Chief Product Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-22 | Allison Swartz | General Counsel | Automatic Disposition | -3,903 | $26.10 |
| 2026-09-16 | Geoffrey Clapp | Chief Product Officer | Sale to Issuer | -819 | $27.38 |
| 2026-09-09 | Kevin Gordon | Independent Director | Derivative Exercise and Sale | -22,000 | $13.00–27.24 |
| 2026-09-03 | Mark Livingston | Chief Financial Officer | Sale to Issuer | -479 | $26.61 |
| 2026-09-03 | Allison Swartz | General Counsel | Sale to Issuer | -1,307 | $26.29–26.61 |
| 2026-09-02 | Peter Anevski | Chief Executive Officer | Sale to Issuer | -5,361 | $26.29 |
| 2026-09-02 | Mark Livingston | Chief Financial Officer | Sale to Issuer | -1,756 | $25.66–26.29 |
| 2026-08-27 | Allison Swartz | General Counsel | Sale to Issuer | -1,352 | $25.86 |
| 2026-07-13 | Melissa Cummings | Chief Operating Officer | Sale to Issuer | -1,193 | $31.98 |
| 2026-07-13 | Melissa Cummings | Chief Operating Officer | Automatic Disposition | -2,244 | $31.60 |
| 2026-06-16 | Geoffrey Clapp | Chief Product Officer | Sale to Issuer | -819 | $26.60 |
| 2026-06-03 | Mark Livingston | Chief Financial Officer | Sale to Issuer | -1,421 | $24.99–25.12 |
| 2026-06-03 | Mark Livingston | Chief Financial Officer | Automatic Disposition | -2,517 | $25.50 |
| 2026-06-03 | Allison Swartz | General Counsel | Sale to Issuer | -1,015 | $24.99–25.12 |
| 2026-06-03 | Allison Swartz | General Counsel | Automatic Disposition | -1,798 | $25.02–25.08 |
| 2026-06-03 | Allison Swartz | General Counsel | Intent to Sell (Form 144) | -599 | $25.08 |
| 2026-06-02 | Peter Anevski | Chief Executive Officer | Sale to Issuer | -5,361 | $25.12 |
| 2026-06-02 | Allison Swartz | General Counsel | Intent to Sell (Form 144) | -1,199 | $25.02 |
| 2026-06-01 | Geoffrey Clapp | Chief Product Officer | Derivative Exercise and Sale | -12,909 | $20.91–25.58 |
| 2026-06-01 | Mark Livingston | Chief Financial Officer | Sale to Issuer | -158 | $26.20 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:01:45 · For reference only, not investment advice and not tailored to your situation.